1. Home
  2. SRPT vs CCS Comparison

SRPT vs CCS Comparison

Compare SRPT & CCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • CCS
  • Stock Information
  • Founded
  • SRPT 1980
  • CCS 2000
  • Country
  • SRPT United States
  • CCS United States
  • Employees
  • SRPT N/A
  • CCS N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • CCS Homebuilding
  • Sector
  • SRPT Health Care
  • CCS Consumer Discretionary
  • Exchange
  • SRPT Nasdaq
  • CCS Nasdaq
  • Market Cap
  • SRPT 1.7B
  • CCS 1.7B
  • IPO Year
  • SRPT 1997
  • CCS 2014
  • Fundamental
  • Price
  • SRPT $21.70
  • CCS $64.44
  • Analyst Decision
  • SRPT Hold
  • CCS Buy
  • Analyst Count
  • SRPT 29
  • CCS 5
  • Target Price
  • SRPT $46.15
  • CCS $80.75
  • AVG Volume (30 Days)
  • SRPT 22.8M
  • CCS 343.0K
  • Earning Date
  • SRPT 08-06-2025
  • CCS 07-23-2025
  • Dividend Yield
  • SRPT N/A
  • CCS 1.78%
  • EPS Growth
  • SRPT N/A
  • CCS N/A
  • EPS
  • SRPT N/A
  • CCS 8.26
  • Revenue
  • SRPT $2,481,531,000.00
  • CCS $4,314,251,000.00
  • Revenue This Year
  • SRPT $3.52
  • CCS N/A
  • Revenue Next Year
  • SRPT N/A
  • CCS $8.47
  • P/E Ratio
  • SRPT N/A
  • CCS $7.88
  • Revenue Growth
  • SRPT 64.89
  • CCS 5.66
  • 52 Week Low
  • SRPT $10.42
  • CCS $50.42
  • 52 Week High
  • SRPT $144.22
  • CCS $108.42
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 57.32
  • CCS 66.47
  • Support Level
  • SRPT $17.28
  • CCS $59.22
  • Resistance Level
  • SRPT $20.61
  • CCS $67.03
  • Average True Range (ATR)
  • SRPT 1.51
  • CCS 1.90
  • MACD
  • SRPT 0.96
  • CCS 0.67
  • Stochastic Oscillator
  • SRPT 95.91
  • CCS 95.93

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About CCS Century Communities Inc.

Century Communities Inc is engaged in the development, design, construction, marketing, and selling of single-family attached and detached homes. It has five homebuilding segments: West, Mountain, Texas, Southeast, and Century Complete. Its sixth reportable segment is financial services operations, which provides mortgage, title, and insurance services to homebuyers. It has acquired land for homebuilding operations with the primary intent to develop and construct single-family detached or attached homes for sale on the acquired land. The company sells homes through its sales representatives and independent real estate brokers. The company generates the majority of its revenue from the Mountain segment.

Share on Social Networks: